Page last updated: 2024-12-08

my 12-62c

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

MY 12-62c: from Pseudomonas methanica KY4634 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

2-heptyl-4-quinolone : A quinolone consisting of quinolin-4(1H)-one carrying a heptyl substituent at position 2. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

2-heptyl-4-hydroxyquinoline : A monohydroxyquinoline that is 4-hydroxyquinoline bearing an additional heptyl substituent at position 2. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID164974
CHEMBL ID527817
CHEBI ID62219
CHEBI ID75306
SCHEMBL ID170164
MeSH IDM0143008

Synonyms (35)

Synonym
my-12-62c
TCMDC-132026 ,
CHEMBL527817
chebi:62219 ,
2503-80-2
2-heptyl-1h-quinolin-4-one
2-heptylquinolin-4(1h)-one ,
2-heptyl-4-quinolone
2-heptyl-4-hydroxyquinoline
4-hydroxy-2-heptylquinoline
HHQ ,
2-heptyl-4(1h)-quinolone
4-quinolinol, 2-heptyl-
my 12-62c
my12-62c
pseudan vii
2-heptylquinolin-4-ol
CHEBI:75306
40522-46-1
C20643
AKOS015899644
UYRHHBXYXSYGHA-UHFFFAOYSA-N
SCHEMBL170164
DTXSID00179740
mfcd16619170
AS-59174
2-heptyl-1,4-dihydroquinolin-4-one
hlh ,
2-heptyl-1~{h}-quinolin-4-one
FT-0764828
2-n-heptyl-4-hydroxyquinoline
W11284
SB72058
EN300-7420523
Z1741979976
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (4)

RoleDescription
antibacterial agentA substance (or active part thereof) that kills or slows the growth of bacteria.
iron chelatornull
signalling moleculeA molecular messenger in which the molecule is specifically involved in transmitting information between cells. Such molecules are released from the cell sending the signal, cross over the gap between cells by diffusion, and interact with specific receptors in another cell, triggering a response in that cell by activating a series of enzyme controlled reactions which lead to changes inside the cell.
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
antibacterial agentA substance (or active part thereof) that kills or slows the growth of bacteria.
iron chelatornull
signalling moleculeA molecular messenger in which the molecule is specifically involved in transmitting information between cells. Such molecules are released from the cell sending the signal, cross over the gap between cells by diffusion, and interact with specific receptors in another cell, triggering a response in that cell by activating a series of enzyme controlled reactions which lead to changes inside the cell.
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
monohydroxyquinolineA hydroxyquinoline carrying a single hydroxy substituent.
quinolone
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
2-heptyl-3-hydroxy-4(1H)-quinolone biosynthesis319
superpathway of quinolone and alkylquinolone biosynthesis724

Bioassays (14)

Assay IDTitleYearJournalArticle
AID1127248Aqueous solubility of the compound in 2% DMSO at pH 7.4 by HPLC analysis2014European journal of medicinal chemistry, May-22, Volume: 79Optimization of anti-virulence PqsR antagonists regarding aqueous solubility and biological properties resulting in new insights in structure-activity relationships.
AID1487122Antiplasmodial activity against chloroquine/mefloquine-resistant Plasmodium falciparum Dd2 incubated for 72 hrs by SYBR green 1 dye based fluorescence assay2017Bioorganic & medicinal chemistry, 08-01, Volume: 25, Issue:15
Isolation, structure elucidation, and synthesis of antiplasmodial quinolones from Crinum firmifolium.
AID1674266Cytotoxicity against human HeLa cells assessed as reduction in cell viability2020Journal of natural products, 07-24, Volume: 83, Issue:7
Isolation of 2-Alkyl-4-quinolones with Unusual Side Chains from a Chinese
AID1127252Agonist activity at Pseudomonas aeruginosa PqsR expressed in Escherichia coli DH5alpha assessed as induction of transcriptional activity at 1 uM by beta-galactosidase reporter gene assay relative to PQS2014European journal of medicinal chemistry, May-22, Volume: 79Optimization of anti-virulence PqsR antagonists regarding aqueous solubility and biological properties resulting in new insights in structure-activity relationships.
AID1487124Antiproliferative activity against human A2780 cells after 2 days by Alamar blue assay2017Bioorganic & medicinal chemistry, 08-01, Volume: 25, Issue:15
Isolation, structure elucidation, and synthesis of antiplasmodial quinolones from Crinum firmifolium.
AID1674264Antibacterial activity against Staphylococcus epidermidis2020Journal of natural products, 07-24, Volume: 83, Issue:7
Isolation of 2-Alkyl-4-quinolones with Unusual Side Chains from a Chinese
AID1674265Antibacterial activity against Staphylococcus aureus2020Journal of natural products, 07-24, Volume: 83, Issue:7
Isolation of 2-Alkyl-4-quinolones with Unusual Side Chains from a Chinese
AID1487123Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum 3D7 incubated for 72 hrs by SYBR green 1 dye based fluorescence assay2017Bioorganic & medicinal chemistry, 08-01, Volume: 25, Issue:15
Isolation, structure elucidation, and synthesis of antiplasmodial quinolones from Crinum firmifolium.
AID1487125Selectivity ratio of IC50 for human A2780 cells to IC50 for chloroquine/mefloquine-resistant Plasmodium falciparum Dd22017Bioorganic & medicinal chemistry, 08-01, Volume: 25, Issue:15
Isolation, structure elucidation, and synthesis of antiplasmodial quinolones from Crinum firmifolium.
AID1159585Biochemical screen of P. falciparum CDPK12016PloS one, , Volume: 11, Issue:3
Biochemical Screening of Five Protein Kinases from Plasmodium falciparum against 14,000 Cell-Active Compounds.
AID1159587Biochemical screen of P. falciparum PK72016PloS one, , Volume: 11, Issue:3
Biochemical Screening of Five Protein Kinases from Plasmodium falciparum against 14,000 Cell-Active Compounds.
AID1159589Biochemical screen of P. falciparum MAPK22016PloS one, , Volume: 11, Issue:3
Biochemical Screening of Five Protein Kinases from Plasmodium falciparum against 14,000 Cell-Active Compounds.
AID1159588Biochemical screen of P. falciparum CDPK42016PloS one, , Volume: 11, Issue:3
Biochemical Screening of Five Protein Kinases from Plasmodium falciparum against 14,000 Cell-Active Compounds.
AID1159586Biochemical screen of P. falciparum PK62016PloS one, , Volume: 11, Issue:3
Biochemical Screening of Five Protein Kinases from Plasmodium falciparum against 14,000 Cell-Active Compounds.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (41)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (9.76)18.7374
1990's0 (0.00)18.2507
2000's5 (12.20)29.6817
2010's25 (60.98)24.3611
2020's7 (17.07)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.37

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.37 (24.57)
Research Supply Index3.74 (2.92)
Research Growth Index5.11 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.37)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (4.88%)6.00%
Case Studies0 (0.00%)4.05%
Observational1 (2.44%)0.25%
Other38 (92.68%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]